|
DCAF12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.50841578011796E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.37490019369579E-10 |
| Normal-vs-Stage2 |
8.1611000000037E-05 |
| Normal-vs-Stage3 |
2.90729662566491E-11 |
| Normal-vs-Stage4 |
7.8846928985854E-12 |
| Stage1-vs-Stage2 |
5.445600E-01 |
| Stage1-vs-Stage3 |
6.960400E-02 |
| Stage1-vs-Stage4 |
1.690500E-02 |
| Stage2-vs-Stage3 |
1.014780E-01 |
| Stage2-vs-Stage4 |
3.057600E-02 |
| Stage3-vs-Stage4 |
3.802400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.76743122546486E-12 |
| Normal-vs-AfricanAmerican |
9.69579999999803E-05 |
| Normal-vs-Asian |
3.97090005321843E-09 |
| Caucasian-vs-AfricanAmerican |
6.263400E-01 |
| Caucasian-vs-Asian |
5.158200E-01 |
| AfricanAmerican-vs-Asian |
3.500400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.24430021841704E-10 |
| Normal-vs-Female |
1.38330458199221E-11 |
| Male-vs-Female |
3.955200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.91010004982439E-09 |
| Normal-vs-Age(41-60Yrs) |
1.43040024269681E-11 |
| Normal-vs-Age(61-80Yrs) |
3.11280001774605E-10 |
| Normal-vs-Age(81-100Yrs) |
1.740320E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.504980E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.580800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.596000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.410800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.055000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.016800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.724160E-01 |
| Classical-VS-Follicular |
9.985000E-01 |
| Classical-VS-Other |
2.454600E-01 |
| Classical-VS-Normal |
6.03339600502295E-11 |
| Tall-VS-Follicular |
2.647600E-01 |
| Tall-VS-Other |
6.395000E-01 |
| Tall-VS-Normal |
6.20860000077883E-08 |
| Follicular-VS-Other |
3.236800E-01 |
| Follicular-VS-Normal |
3.78810000034591E-07 |
| Other-VS-Normal |
4.194000E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.81660036907761E-10 |
| Normal-vs-N1 |
4.30529945028013E-10 |
| N0-vs-N1 |
1.230240E-01 |
|
|
